HUGHES ON HEADLINES “Public health shouldn’t be a secondary consideration for regulator”
It is pretty easy to view drug companies as Dr. Jekyll and Mr. Hyde type entities. For those who are relieved of symptoms or illness by proprietary drugs, they do good and important work. For those who struggle with side effects, receive little or no relief, have adverse reactions – or [Read more]
